Download PDF
Semin Neurol 2008; 28(4): 423-434
DOI: 10.1055/s-0028-1083683
© Thieme Medical Publishers

Brain Single Photon Emission Computed Tomography: Technological Aspects and Clinical Applications

Joseph C. Masdeu1 , Javier Arbizu2
  • 1Department of Neurology and Neurosurgery, Clínica Universitaria de Navarra, University of Navarra Medical School, and the Center for Applied Medical Research, Pamplona, Spain
  • 2Department of Nuclear Medicine, Clínica Universitaria de Navarra, University of Navarra Medical School, and the Center for Applied Medical Research, Pamplona, Spain
Further Information

Publication History

Publication Date:
08 October 2008 (online)

    Permissions and Reprints

ABSTRACT

Single photon emission computed tomography (SPECT) is obtained by the injection of one of a series of compounds that cross the blood-brain barrier and are distributed in the brain according to regional perfusion or to the density of a given receptor. The regional brain distribution of the injected compound can be measured because it is bound to a radioactive substance that emits photons. Emitted photons are collimated to facilitate determining their source and detected with sodium iodine crystal detectors. Finally, the techniques of CT are used to reconstruct the density of photons emitted by each volume element (voxel) of the brain. Less expensive and more widely distributed in nuclear medicine departments than positron emission tomography, SPECT is currently used mainly in the evaluation for epilepsy surgery, of cerebrovascular disease, and of the parkinsonian and other neurodegenerative syndromes. In this article, we discuss the technological aspects of brain SPECT and its clinical neurological applications.

KEYWORDS

Single photon emission computed tomography - brain - brain diseases - neuroimaging

REFERENCES

  • 1 Catafau A M. Brain SPECT in clinical practice. Part I: perfusion.  J Nucl Med. 2001;  42 259-271
    PubMedGoogle Scholar
  • 2 Devous M D. Single-photon emission computed tomography in neurotherapeutics.  NeuroRx. 2005;  2 237-249
    CrossrefPubMedGoogle Scholar
  • 3 Vastenhouw B, Beekman F. Submillimeter total-body murine imaging with U-SPECT-I.  J Nucl Med. 2007;  48 487-493
    PubMedGoogle Scholar
  • 4 Wintermark M, Sesay M, Barbier E et al.. Comparative overview of brain perfusion imaging techniques.  J Neuroradiol. 2005;  32 294-314
    PubMedGoogle Scholar
  • 5 Seibyl J, Jennings D, Tabamo R, Marek K. Unique roles of SPECT brain imaging in clinical and research studies. Lessons from Parkinson's disease research.  Q J Nucl Med Mol Imaging. 2005;  49 215-221
    PubMedGoogle Scholar
  • 6 Catafau A M, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.  Mov Disord. 2004;  19 1175-1182
    CrossrefPubMedGoogle Scholar
  • 7 Masdeu J C. Imaging of stroke with SPECT. In: Babikian V, Wechsler L, Higashida RT Imaging Cerebrovascular Disease. Boston, MA; Butterworth-Heinemann 2003: 131-144
    Google Scholar
  • 8 Aminian A, Strashun A, Rose A. Alternating hemiplegia of childhood: studies of regional cerebral blood flow using 99mTc-hexamethylpropylene amine oxime single-photon emission computed tomography.  Ann Neurol. 1993;  33 43-47
    CrossrefPubMedGoogle Scholar
  • 9 Lewis D H, Longstreth Jr W, Wilkus R, Copass M. Hyperemic receptive aphasia on neuroSPECT.  Clin Nucl Med. 1993;  18 409-412
    CrossrefPubMedGoogle Scholar
  • 10 Matsumoto K, Awata S, Matsuoka H, Nakamura S, Sato M. Chronological changes in brain MRI, SPECT, and EEG in neurosarcoidosis with stroke-like episodes.  Psychiatry Clin Neurosci. 1998;  52 629-633
    CrossrefPubMedGoogle Scholar
  • 11 Berrouschot J, Barthel H, Hesse S, Koster J, Knapp W H, Schneider D. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD-SPECT.  J Cereb Blood Flow Metab. 1998;  18 921-929
    PubMedGoogle Scholar
  • 12 Laloux P, Jamart J, Meurisse H, De-Coster P, Laterre C. Persisting perfusion defect in transient ischemic attacks: a new clinically useful subgroup?.  Stroke. 1996;  27 425-430
    PubMedGoogle Scholar
  • 13 Nuutinen J, Kuikka J, Roivainen R, Vanninen E, Sivenius J. Early serial SPECT in acute middle cerebral artery infarction.  Nucl Med Commun. 2000;  21 425-429
    CrossrefPubMedGoogle Scholar
  • 14 Barthel H, Hesse S, Dannenberg C et al.. Prospective value of perfusion and x-ray attenuation imaging with single-photon emission and transmission computed tomography in acute cerebral ischemia.  Stroke. 2001;  32 1588-1597
    PubMedGoogle Scholar
  • 15 Mahagne M H, Darcourt J, Migneco O et al.. Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery.  Cerebrovasc Dis. 2000;  10 364-373
    CrossrefPubMedGoogle Scholar
  • 16 Baird A E, Austin M C, McKay W J, Donnan G A. Sensitivity and specificity of 99mTc-HMPAO SPECT cerebral perfusion measurements during the first 48 hours for the localization of cerebral infarction.  Stroke. 1997;  28 976-980
    PubMedGoogle Scholar
  • 17 Brass L M, Walovitch R C, Joseph J L et al.. The role of single photon emission computed tomography brain imaging with 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke.  J Cereb Blood Flow Metab. 1994;  14 S91-S98
    PubMedGoogle Scholar
  • 18 Berrouschot J, Barthel H, von Kummer R, Knapp W H, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema.  Stroke. 1998;  29 2556-2562
    PubMedGoogle Scholar
  • 19 Alexandrov A V, Black S E, Ehrlich L E et al.. Simple visual analysis of brain perfusion on HMPAO SPECT predicts early outcome in acute stroke.  Stroke. 1996;  27 1537-1542
    PubMedGoogle Scholar
  • 20 Hirano T, Read S J, Abbott D F et al.. Prediction of the final infarct volume within 6 h of stroke using single photon emission computed tomography with technetium-99m hexamethylpropylene amine oxime.  Cerebrovasc Dis. 2001;  11 119-127
    PubMedGoogle Scholar
  • 21 Alexandrov A V, Masdeu J C, Devous Sr M, Black S E, Grotta J C. Brain single-photon emission CT with HMPAO and safety of thrombolytic therapy in acute ischemic stroke. Proceedings of the meeting of the SPECT Safe Thrombolysis Study Collaborators and the members of the Brain Imaging Council of the Society of Nuclear Medicine.  Stroke. 1997;  28 1830-1834
    PubMedGoogle Scholar
  • 22 Baron J C. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications.  Cerebrovasc Dis. 2001;  11 2-8
    PubMedGoogle Scholar
  • 23 Karonen J O, Vanninen R L, Liu Y et al.. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth.  Stroke. 1999;  30 1583-1590
    PubMedGoogle Scholar
  • 24 Liu Y, Karonen J O, Vanninen R L et al.. Cerebral hemodynamics in human acute ischemic stroke: a study with diffusion- and perfusion-weighted magnetic resonance imaging and SPECT.  J Cereb Blood Flow Metab. 2000;  20 910-920
    PubMedGoogle Scholar
  • 25 Heiss W D. Ischemic penumbra: evidence from functional imaging in man.  J Cereb Blood Flow Metab. 2000;  20 1276-1293
    CrossrefPubMedGoogle Scholar
  • 26 Ogasawara K, Ogawa A, Ezura M et al.. Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT.  J Nucl Med. 2001;  42 543-547
    PubMedGoogle Scholar
  • 27 Ogasawara K, Ogawa A, Ezura M, Konno H, Suzuki M, Yoshimoto T. Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion.  AJNR Am J Neuroradiol. 2001;  22 48-53
    PubMedGoogle Scholar
  • 28 Ryu Y H, Chung T S, Yoon P H et al.. Evaluation of reperfusion and recovery of brain function before and after intracarotid arterial urokinase therapy in acute cerebral infarction with brain SPECT.  Clin Nucl Med. 1999;  24 566-571
    CrossrefPubMedGoogle Scholar
  • 29 Ueda T, Sakaki S, Yuh W T, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography.  J Cereb Blood Flow Metab. 1999;  19 99-108
    PubMedGoogle Scholar
  • 30 Sasaki O, Takeuchi S, Koizumi T, Koike T, Tanaka R. Complete recanalization via fibrinolytic therapy can reduce the number of ischemic territories that progress to infarction.  AJNR Am J Neuroradiol. 1996;  17 1661-1668
    PubMedGoogle Scholar
  • 31 Grotta J C, Alexandrov A V. tPA-associated reperfusion after acute stroke demonstrated by SPECT.  Stroke. 1998;  29 429-432
    PubMedGoogle Scholar
  • 32 Berrouschot J, Barthel H, Hesse S, Knapp W H, Schneider D, von Kummer R. Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischemic stroke and thrombolytic therapy.  Stroke. 2000;  31 1545-1551
    PubMedGoogle Scholar
  • 33 Nakano S, Iseda T, Ikeda T, Yoneyama T, Wakisaka S. Thresholds of ischemia salvageable with intravenous tissue plasminogen activator therapy: evaluation with cerebral blood flow single-photon emission computed tomographic measurements.  Neurosurgery. 2000;  47 68-71 discussion 71-63
    CrossrefPubMedGoogle Scholar
  • 34 Umemura A, Suzuka T, Yamada K. Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options.  J Neurol Neurosurg Psychiatry. 2000;  69 472-478
    CrossrefPubMedGoogle Scholar
  • 35 Yasaka M, O'Keefe G J, Chambers B R et al.. Streptokinase in acute stroke: effect on reperfusion and recanalization. Australian Streptokinase Trial Study Group.  Neurology. 1998;  50 626-632
    PubMedGoogle Scholar
  • 36 Rossler A, Berrouschot J, Barthel H, Hesse S, Koster J, Schneider D. Potential of rheopheresis for the treatment of acute ischemic stroke when initiated between 6 and 12 hours.  Ther Apher. 2000;  4 358-362
    PubMedGoogle Scholar
  • 37 Berrouschot J, Barthel H, Koster J et al.. Extracorporeal rheopheresis in the treatment of acute ischemic stroke: a randomized pilot study.  Stroke. 1999;  30 787-792
    PubMedGoogle Scholar
  • 38 Kita T, Hayashi K, Yamamoto M et al.. Does supplementation of contrast MR imaging with thallium-201 brain SPECT improve differentiation between benign and malignant ring-like contrast-enhanced cerebral lesions?.  Ann Nucl Med. 2007;  21 251-256
    CrossrefPubMedGoogle Scholar
  • 39 Vallejos V, Balana C, Fraile M et al.. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.  J Neurooncol. 2002;  59 81-90
    CrossrefPubMedGoogle Scholar
  • 40 Plotkin M, Amthauer H, Eisenacher J et al.. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.  Neuroradiology. 2005;  47 18-26
    CrossrefPubMedGoogle Scholar
  • 41 Tucker K A, Robertson K R, Lin W et al.. Neuroimaging in human immunodeficiency virus infection.  J Neuroimmunol. 2004;  157 153-162
    CrossrefPubMedGoogle Scholar
  • 42 Masdeu J C, Van Heertum R L, Abdel-Dayem H. Viral infections of the brain.  J Neuroimaging. 1995;  5(suppl 1) S40-S44
    PubMedGoogle Scholar
  • 43 O'Malley J P, Ziessman H A, Kumar P N, Harkness B A, Tall J G, Pierce P F. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201TI single-photon emission computed tomography.  AJR Am J Roentgenol. 1994;  163 417-421
    PubMedGoogle Scholar
  • 44 Ruiz A, Ganz W I, Post M J et al.. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients.  AJNR Am J Neuroradiol. 1994;  15 1885-1894
    PubMedGoogle Scholar
  • 45 Giancola M L, Rizzi E B, Schiavo R et al.. Reduced value of thallium-201 single-photon emission computed tomography in the management of HIV-related focal brain lesions in the era of highly active antiretroviral therapy.  AIDS Res Hum Retroviruses. 2004;  20 584-588
    CrossrefPubMedGoogle Scholar
  • 46 Licho R, Litofsky N S, Senitko M, George M. Inaccuracy of Tl-201 brain SPECT in distinguishing cerebral infections from lymphoma in patients with AIDS.  Clin Nucl Med. 2002;  27 81-86
    CrossrefPubMedGoogle Scholar
  • 47 Kim D G, Lee J I, Lee D S, Lee M C, Choi K S, Han D H. 99mTc-HMPAO labeled leukocyte SPECT in intracranial lesions.  Surg Neurol. 1995;  44 338-345
    CrossrefPubMedGoogle Scholar
  • 48 Masdeu J C, Abdel-Dayem H, Van Heertum R L. Head trauma: use of SPECT.  J Neuroimaging. 1995;  5(suppl 1) S53-S57
    PubMedGoogle Scholar
  • 49 Lee B, Newberg A. Neuroimaging in traumatic brain imaging.  NeuroRx. 2005;  2 372-383
    Google Scholar
  • 50 Cascino G D, So E L, Buchhalter J R, Mullan B P. The current place of single photon emission computed tomography in epilepsy evaluations.  Neuroimaging Clin N Am. 2004;  14 553-561
    CrossrefPubMedGoogle Scholar
  • 51 Ho S S, Berkovic S F, Berlangieri S U et al.. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy.  Ann Neurol. 1995;  37 738-745
    CrossrefPubMedGoogle Scholar
  • 52 Masdeu J C, Zubieta J L, Arbizu J. Neuroimaging as a marker of the onset and progression of Alzheimer's disease.  J Neurol Sci. 2005;  236 55-64
    CrossrefPubMedGoogle Scholar
  • 53 Johnson K A, Jones K, Holman B L et al.. Preclinical prediction of Alzheimer's disease using SPECT.  Neurology. 1998;  50 1563-1571
    CrossrefPubMedGoogle Scholar
  • 54 Jagust W, Thisted R, Devous Sr M D et al.. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study.  Neurology. 2001;  56 950-956
    PubMedGoogle Scholar
  • 55 Johnson K A, Lopera F, Jones K et al.. Presenilin-1-associated abnormalities in regional cerebral perfusion.  Neurology. 2001;  56 1545-1551
    PubMedGoogle Scholar
  • 56 Walker Z, Costa D C, Walker R W et al.. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.  J Neurol Neurosurg Psychiatry. 2002;  73 134-140
    CrossrefPubMedGoogle Scholar
  • 57 O'Brien J T, Colloby S, Fenwick J et al.. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.  Arch Neurol. 2004;  61 919-925
    CrossrefPubMedGoogle Scholar
  • 58 Ravina B, Eidelberg D, Ahlskog J E et al.. The role of radiotracer imaging in Parkinson disease.  Neurology. 2005;  64 208-215
    PubMedGoogle Scholar
  • 59 Brooks D J. PET and SPECT in CNS drug development.  NeuroRx. 2005;  2 226-236
    CrossrefPubMedGoogle Scholar
  • 60 Masdeu J C, Bakshi R. Neuroimaging: anything to do with neurotherapeutics?.  NeuroRx. 2005;  2 163-166
    CrossrefPubMedGoogle Scholar
  • 61 Eckert T, Eidelberg D. Neuroimaging and therapeutics in movement disorders.  NeuroRx. 2005;  2 361-371
    CrossrefPubMedGoogle Scholar
  • 62 Facco E, Zucchetta P, Munari M et al.. 99mTc-HMPAO SPECT in the diagnosis of brain death.  Intensive Care Med. 1998;  24 911-917
    CrossrefPubMedGoogle Scholar

Joseph C MasdeuM.D. Ph.D. 

Neurosciences, CUN, University of Navarre

Pamplona, Spain

Email: masdeu@unav.es

      >